Rapid response in the COVID-19 pandemic: a Delphi study from the European Pediatric Dialysis Working Group

Fabian Eibensteiner1, Valentin Ritschl2, Gema Ariceta3

  • 1Division of Pediatric Nephrology and Gastroenterology, Comprehensive Center for Pediatrics, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Vienna, Austria.

Insights

Expert pediatric nephrologists rapidly shared knowledge on COVID-19 care for children with chronic kidney disease. This Delphi study provided timely guidance on testing, therapeutics, and clinical management during the pandemic.

Area of Science:

  • Pediatric Nephrology
  • Infectious Diseases
  • Public Health

Background:

  • COVID-19 pandemic presented unique challenges for pediatric chronic kidney disease (CKD) patients.
  • Limited data existed for evidence-based recommendations in this vulnerable population.
  • Urgent need for expert consensus on managing pediatric CKD during the COVID-19 health emergency.

Purpose of the Study:

  • To rapidly collect and synthesize expert knowledge on managing children with CKD during the COVID-19 pandemic.
  • To establish timely, evidence-based practice recommendations for pediatric nephrologists.
  • To address critical care aspects specific to pediatric CKD patients affected by COVID-19.

Main Methods:

  • A four-round, multi-center Delphi exercise involving 13 European centers.
  • Utilized the European Pediatric Dialysis Working Group (EPDWG) network.
  • Employed mixed methods, including qualitative analysis and descriptive statistics.

Main Results:

  • Identified 13 key COVID-19 related topics requiring guidance for pediatric CKD care.
  • Key themes included testing strategies, therapeutic use, transmission prevention, and clinical care modifications.
  • Observed variations in center-specific practices influenced by local regulations and guidelines.

Conclusions:

  • Qualitative expert knowledge is crucial when real-time quantitative data is scarce during a pandemic.
  • The Delphi exercise effectively analyzed pediatric nephrologists' responses to COVID-19 using mixed methodologies.
  • Rapid knowledge sharing is vital for optimal medical management of specific patient groups in international healthcare systems.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
148
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
207
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
172
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
190
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
205
Dialysis01:27

Dialysis

Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
1.0K